Novel pyridine‐2,4,6‐tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type‐2 diabetes mellitus: In vitro studies against yeast α‐ and β‐glucosidase and in silico molecular modeling
- 1 December 2017
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 351 (1)
Abstract
A range of novel pyridine‐2,4,6‐tricarbohydrazide thiourea compounds (4a–i) were synthesized in good to excellent yields (63–92%). The enzyme inhibitory potentials of these compounds were investigated against α‐ and β‐glucosidases because these enzymes play a crucial role in treating type‐2 diabetes mellitus (T2DM). As compared to the reference compound acarbose (IC50 38.22 ± 0.12 μM), compounds 4i (IC50 25.49 ± 0.67 μM), 4f (IC50 28.91 ± 0.43 μM), 4h (IC50 30.66 ± 0.52 μM), and 4e (IC50 35.01 ± 0.45 μM) delivered better inhibition against α‐glucosidase and were quite inactive/completely inactive against β‐glucosidase. The structure–activity relationship of these compounds was developed and elaborated with the help of molecular docking studies.Keywords
Funding Information
- Higher Education Commission, Pakistan (20‐3971/NRPU/R, D/HEC/14/242)
This publication has 24 references indexed in Scilit:
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Synthesis and Biological Characterisation of Novel N‐Alkyl‐Deoxynojirimycin α‐Glucosidase InhibitorsChemBioChem, 2009
- Glycoprotein Synthesis: An UpdateChemical Reviews, 2008
- Discovery and biological evaluation of novel α-glucosidase inhibitors with in vivo antidiabetic effectBioorganic & Medicinal Chemistry Letters, 2008
- The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serumGlycobiology, 2008
- Docking and scoring in virtual screening for drug discovery: methods and applicationsNature Reviews Drug Discovery, 2004
- Structure–activity relationships of trans-cinnamic acid derivatives on α-glucosidase inhibitionBioorganic & Medicinal Chemistry Letters, 2004
- Glycosidase inhibitors: update and perspectives on practical useGlycobiology, 2003
- MiglitolDrugs, 2000
- Safety Profile of Acarbose, an α-Glucosidase InhibitorDrugs, 1992